Male Hypogonadism Global Market Report 2025

Male Hypogonadism Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on male hypogonadism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for male hypogonadism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The male hypogonadism market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Klinefelters Syndrome; Kallmann Syndrome; Pituitary Disorders; Other Types

2) By Drug Delivery: Topical Gels; Injectables; Transdermal Patches; Other Drug Deliveries

3) By Therapy: Testosterone Therapy; Gonadotropin-Releasing Hormone Therapy

Subsegments:

1) By Klinefelter's Syndrome: 47,XXY Syndrome; Other Variants

2) By Kallmann Syndrome: Isolated Kallmann Syndrome; Syndromic Kallmann Syndrome

3) By Pituitary Disorders: Hypopituitarism; Pituitary Tumors; Other Pituitary Disorders

4) By Other Types: Androgen Insensitivity Syndrome; Testicular Dysgenesis Syndrome; Genetic Mutations And Disorders

Companies Mentioned: Pfizer Inc.; Bayer AG; Eli Lilly and Company Ltd.; Endo International plc.; Merck & Co. Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Male Hypogonadism Market Characteristics
3. Male Hypogonadism Market Trends And Strategies
4. Male Hypogonadism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Male Hypogonadism Growth Analysis And Strategic Analysis Framework
5.1. Global Male Hypogonadism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Male Hypogonadism Market Growth Rate Analysis
5.4. Global Male Hypogonadism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Male Hypogonadism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Male Hypogonadism Total Addressable Market (TAM)
6. Male Hypogonadism Market Segmentation
6.1. Global Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Klinefelters Syndrome
Kallmann Syndrome
Pituitary Disorders
Other Types
6.2. Global Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Gels
Injectables
Transdermal Patches
Other Drug Deliveries
6.3. Global Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Testosterone Therapy
Gonadotropin-Releasing Hormone Therapy
6.4. Global Male Hypogonadism Market, Sub-Segmentation Of Klinefelter's Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
47,XXY Syndrome
Other Variants
6.5. Global Male Hypogonadism Market, Sub-Segmentation Of Kallmann Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Isolated Kallmann Syndrome
Syndromic Kallmann Syndrome
6.6. Global Male Hypogonadism Market, Sub-Segmentation Of Pituitary Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypopituitarism
Pituitary Tumors
Other Pituitary Disorders
6.7. Global Male Hypogonadism Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Androgen Insensitivity Syndrome
Testicular Dysgenesis Syndrome
Genetic Mutations And Disorders
7. Male Hypogonadism Market Regional And Country Analysis
7.1. Global Male Hypogonadism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Male Hypogonadism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Male Hypogonadism Market
8.1. Asia-Pacific Male Hypogonadism Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Male Hypogonadism Market
9.1. China Male Hypogonadism Market Overview
9.2. China Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Male Hypogonadism Market
10.1. India Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Male Hypogonadism Market
11.1. Japan Male Hypogonadism Market Overview
11.2. Japan Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Male Hypogonadism Market
12.1. Australia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Male Hypogonadism Market
13.1. Indonesia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Male Hypogonadism Market
14.1. South Korea Male Hypogonadism Market Overview
14.2. South Korea Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Male Hypogonadism Market
15.1. Western Europe Male Hypogonadism Market Overview
15.2. Western Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Male Hypogonadism Market
16.1. UK Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Male Hypogonadism Market
17.1. Germany Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Male Hypogonadism Market
18.1. France Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Male Hypogonadism Market
19.1. Italy Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Male Hypogonadism Market
20.1. Spain Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Male Hypogonadism Market
21.1. Eastern Europe Male Hypogonadism Market Overview
21.2. Eastern Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Male Hypogonadism Market
22.1. Russia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Male Hypogonadism Market
23.1. North America Male Hypogonadism Market Overview
23.2. North America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Male Hypogonadism Market
24.1. USA Male Hypogonadism Market Overview
24.2. USA Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Male Hypogonadism Market
25.1. Canada Male Hypogonadism Market Overview
25.2. Canada Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Male Hypogonadism Market
26.1. South America Male Hypogonadism Market Overview
26.2. South America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Male Hypogonadism Market
27.1. Brazil Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Male Hypogonadism Market
28.1. Middle East Male Hypogonadism Market Overview
28.2. Middle East Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Male Hypogonadism Market
29.1. Africa Male Hypogonadism Market Overview
29.2. Africa Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Male Hypogonadism Market Competitive Landscape And Company Profiles
30.1. Male Hypogonadism Market Competitive Landscape
30.2. Male Hypogonadism Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Eli Lilly and Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Endo International plc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Male Hypogonadism Market Other Major And Innovative Companies
31.1. Ferring Pharmaceuticals
31.2. Finox Biotech AG
31.3. Teva Pharmaceutical Industries Ltd.
31.4. AbbVie Inc.
31.5. Perrigo Company plc
31.6. IBSA Institut Biochimique SA
31.7. Sun Pharmaceutical Industries Limited
31.8. Glenmark Pharmaceuticals Limited
31.9. Antares Pharma Inc.
31.10. Zydus Cadila LLC
31.11. Besins Healthcare Ltd.
31.12. Clarus Therapeutics Holdings Inc.
31.13. Foresee Pharmaceuticals Co. Ltd.
31.14. Lipocine Inc.
31.15. Myovant Sciences Ltd.
32. Global Male Hypogonadism Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Male Hypogonadism Market
34. Recent Developments In The Male Hypogonadism Market
35. Male Hypogonadism Market High Potential Countries, Segments and Strategies
35.1 Male Hypogonadism Market In 2029 - Countries Offering Most New Opportunities
35.2 Male Hypogonadism Market In 2029 - Segments Offering Most New Opportunities
35.3 Male Hypogonadism Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings